131 related articles for article (PubMed ID: 24122958)
1. miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer.
Huang D; Wang H; Liu R; Li H; Ge S; Bai M; Deng T; Yao G; Ba Y
J Cell Biochem; 2014 Mar; 115(3):549-56. PubMed ID: 24122958
[TBL] [Abstract][Full Text] [Related]
2. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
4. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
Tanaka K; Miyata H; Yamasaki M; Sugimura K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S607-15. PubMed ID: 23838916
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
8. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
Zheng J; Dong P; Gao S; Wang N; Yu F
Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
[TBL] [Abstract][Full Text] [Related]
10. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer.
Kim SY; Jeon TY; Choi CI; Kim DH; Kim DH; Kim GH; Ryu DY; Lee BE; Kim HH
J Mol Diagn; 2013 Sep; 15(5):661-9. PubMed ID: 23806809
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer.
Naito Y; Yasuno K; Tagawa H; Sakamoto N; Oue N; Yashiro M; Sentani K; Goto K; Shinmei S; Oo HZ; Yanagihara K; Hirakawa K; Yasui W
Oncol Rep; 2014 Oct; 32(4):1720-6. PubMed ID: 25051317
[TBL] [Abstract][Full Text] [Related]
12. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Zhang HP; Sun FB; Li SJ
Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
[TBL] [Abstract][Full Text] [Related]
14. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
Komatsu S; Ichikawa D; Tsujiura M; Konishi H; Takeshita H; Nagata H; Kawaguchi T; Hirajima S; Arita T; Shiozaki A; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Anticancer Res; 2013 Jan; 33(1):271-6. PubMed ID: 23267156
[TBL] [Abstract][Full Text] [Related]
16. Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer.
Iwaya T; Fukagawa T; Suzuki Y; Takahashi Y; Sawada G; Ishibashi M; Kurashige J; Sudo T; Tanaka F; Shibata K; Endo F; Katagiri H; Ishida K; Kume K; Nishizuka S; Iinuma H; Wakabayashi G; Mori M; Sasako M; Mimori K
Clin Cancer Res; 2013 Dec; 19(23):6438-49. PubMed ID: 24097871
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
[TBL] [Abstract][Full Text] [Related]
18. The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy.
Song J; Yin J; Bai Z; Zhang J; Meng H; Cai J; Deng W; Ma X; Zhang Z
Dig Dis Sci; 2017 May; 62(5):1223-1234. PubMed ID: 28341869
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy.
Zhang J; Zhang K; Bi M; Jiao X; Zhang D; Dong Q
Anticancer Drugs; 2014 Mar; 25(3):346-52. PubMed ID: 24304648
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]